Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Psoriasis × Adalimumab × Clear all

Phase

Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Psoriasis 2 Spondylitis, Ankylosing 1 Plaque Psoriasis 1 Osteoarthritis 1 Crohn Disease 1 Colitis, Ulcerative 1

Interventions

tofacitinib 7 Etanercept 3 Adalimumab 2 secukinumab 1 apremilast 1 Methotrexate 1 Anti-Infective Agents, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02762955 2021-09-08

CALYPSO

Biocad

Phase 3 Completed

Psoriasis

NCT02196701 2018-03-19

CLEAR

AbbVie

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡